These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6334639)

  • 21. Analysis of the oligosaccharides on the HLA-DR and DC1 B cell antigens.
    Shackelford DA; Strominger JL
    J Immunol; 1983 Jan; 130(1):274-82. PubMed ID: 6600184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HLA-DR antigens have polymorphic light chains and invariant heavy chains as assessed by lysine-containing tryptic peptide analysis.
    Kaufman JF; Andersen RL; Strominger JL
    J Exp Med; 1980 Aug; 152(2 Pt 2):37s-53s. PubMed ID: 6774044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dissociation in expression of MB1/MT1 and DR1 alloantigens in mutants of a lymphoblastoid cell line.
    DeMars R; Chang CC; Marrari M; Duquesnoy RJ; Noreen H; Segall M; Bach FH
    J Immunol; 1983 Sep; 131(3):1318-21. PubMed ID: 6411812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The nonpolymorphic MHC class II isotype, HLA-DQA2, is expressed on the surface of B lymphoblastoid cells.
    Rudy GB; Lew AM
    J Immunol; 1997 Mar; 158(5):2116-25. PubMed ID: 9036956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormal association between invariant chain and HLA class II alpha and beta chains in chronic lymphocytic leukemia.
    Veenstra H; Jacobs P; Dowdle EB
    Cell Immunol; 1996 Jul; 171(1):68-73. PubMed ID: 8660839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human TCR-gamma/delta alloreactive response to HLA-DR molecules. Comparison with response of TCR-alpha/beta.
    Flament C; Benmerah A; Bonneville M; Triebel F; Mami-Chouaib F
    J Immunol; 1994 Oct; 153(7):2890-904. PubMed ID: 8089476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biochemical characterization of Ia alloantigens in guinea pigs. II. Comparative peptide mapping of Ia antigens from B cells, T cells, and macrophages.
    Lyons CR; Cook RG; Tucker TF; Uhr JW
    J Immunol; 1981 Nov; 127(5):1885-8. PubMed ID: 6975302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The soluble pool of beta 2-microglobulin free HLA class I alpha-chains. Qualitative and quantitative characterization.
    Pickl WF; Majdic O; Faé I; Reuschel R; Holter W; Knapp W
    J Immunol; 1993 Sep; 151(5):2613-22. PubMed ID: 8360481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biochemical analysis of the polymorphism of three HLA-D region antigens.
    de Kretser T; Crumpton MJ; Bodmer JG; Bodmer WF
    Mol Biol Med; 1983 Jul; 1(1):59-76. PubMed ID: 6593560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electrophoretic analysis of HLA-DR2 molecules isolated from HLA-Dw2 and HLA-Dw12 cell lines.
    Takenouchi T; Kasahara M; Ogasawara K; Ikeda H; Ishikawa N; Hawkin S; Wakisaka A; Aizawa M
    J Immunogenet; 1985 Feb; 12(1):65-9. PubMed ID: 3876392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serologic dissection of HLA-D specificities by the use of monoclonal antibodies. II. Distinction between HLA-Dw2 and HLA-Dw12.
    Kasahara M; Takenouchi T; Ikeda H; Ogasawara K; Okuyama T; Ishikawa N; Wakisaka A; Kikuchi Y; Aizawa M
    Immunogenetics; 1983; 18(5):525-36. PubMed ID: 6196285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human B-cell alloantigens DC1, MT1, and LB12 are identical to each other but distinct from the HLA-DR antigen.
    Shackelford DA; Mann DL; van Rood JJ; Ferrara GB; Strominger JL
    Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4566-70. PubMed ID: 6974868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell-surface expression of human histocompatibility leucocyte antigen (HLA) class II-associated invariant chain (CD74) does not always correlate with cell-surface expression of HLA class II molecules.
    Wilson KM; Labeta MO; Pawelec G; Fernandez N
    Immunology; 1993 Jun; 79(2):331-5. PubMed ID: 8344710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implications of the invariant gamma-chain on the intracellular transport of class II histocompatibility antigens.
    Claesson-Welsh L; Peterson PA
    J Immunol; 1985 Nov; 135(5):3551-7. PubMed ID: 3862712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cross-linking of HLA class II antigens modulates the release of tumor necrosis factor-alpha by the EBV-B lymphoblastoid cell line JY.
    Altomonte M; Pucillo C; Damante G; Maio M
    J Immunol; 1993 Nov; 151(10):5115-22. PubMed ID: 8228213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Demonstration of a third structurally distinct human Ia beta chain by two-dimensional gel electrophoresis.
    Karr RW; Kannapell CC; Stein JA; Fuller TC; Duquesnoy RJ; Rodey GE; Mann DL; Gebel HM; Schwartz BD
    J Exp Med; 1982 Aug; 156(2):652-7. PubMed ID: 6980260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surface expression of the invariant chain (CD74) is independent of concomitant expression of major histocompatibility complex class II antigens.
    Henne C; Schwenk F; Koch N; Möller P
    Immunology; 1995 Feb; 84(2):177-82. PubMed ID: 7750992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules.
    Morris P; Shaman J; Attaya M; Amaya M; Goodman S; Bergman C; Monaco JJ; Mellins E
    Nature; 1994 Apr; 368(6471):551-4. PubMed ID: 8139689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biosynthesis and glycosylation of the invariant chain associated with HLA-DR antigens.
    Machamer CE; Cresswell P
    J Immunol; 1982 Dec; 129(6):2564-9. PubMed ID: 6982931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide.
    Bonehill A; Heirman C; Tuyaerts S; Michiels A; Zhang Y; van der Bruggen P; Thielemans K
    Cancer Res; 2003 Sep; 63(17):5587-94. PubMed ID: 14500399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.